"Prostatic Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the PROSTATE.
Descriptor ID |
D011471
|
MeSH Number(s) |
C04.588.945.440.770 C12.294.260.750 C12.294.565.625 C12.758.409.750
|
Concept/Terms |
Prostatic Neoplasms- Prostatic Neoplasms
- Prostate Neoplasms
- Neoplasms, Prostate
- Neoplasm, Prostate
- Prostate Neoplasm
- Neoplasms, Prostatic
- Neoplasm, Prostatic
- Prostatic Neoplasm
Prostate Cancer- Prostate Cancer
- Cancer, Prostate
- Cancers, Prostate
- Prostate Cancers
- Cancer of the Prostate
- Prostatic Cancer
- Cancer, Prostatic
- Cancers, Prostatic
- Prostatic Cancers
- Cancer of Prostate
|
Below are MeSH descriptors whose meaning is more general than "Prostatic Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Prostatic Neoplasms".
This graph shows the total number of publications written about "Prostatic Neoplasms" by people in this website by year, and whether "Prostatic Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 0 | 1 |
1996 | 1 | 0 | 1 |
1997 | 2 | 0 | 2 |
1998 | 7 | 0 | 7 |
1999 | 14 | 1 | 15 |
2000 | 5 | 0 | 5 |
2001 | 2 | 1 | 3 |
2002 | 10 | 1 | 11 |
2003 | 2 | 0 | 2 |
2004 | 5 | 0 | 5 |
2005 | 8 | 0 | 8 |
2006 | 16 | 0 | 16 |
2007 | 11 | 1 | 12 |
2008 | 8 | 1 | 9 |
2009 | 10 | 0 | 10 |
2010 | 10 | 0 | 10 |
2011 | 6 | 1 | 7 |
2012 | 2 | 1 | 3 |
2013 | 12 | 1 | 13 |
2014 | 9 | 0 | 9 |
2015 | 9 | 0 | 9 |
2016 | 11 | 0 | 11 |
2017 | 14 | 0 | 14 |
2018 | 3 | 0 | 3 |
2019 | 6 | 0 | 6 |
2020 | 5 | 1 | 6 |
2021 | 1 | 0 | 1 |
2022 | 4 | 0 | 4 |
2023 | 2 | 0 | 2 |
2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prostatic Neoplasms" by people in Profiles.
-
DNA methylation markers for risk of metastasis in a cohort of men with localized prostate cancer. Epigenetics. 2024 Dec; 19(1):2308920.
-
Screening for Prostate Cancer. N Engl J Med. 2023 Jul 06; 389(1):93-94.
-
The costs and inequities of precision medicine for patients with prostate cancer: A call to action. Urol Oncol. 2023 09; 41(9):369-375.
-
Evaluation of Harms Reporting in U.S. Cancer Screening Guidelines. Ann Intern Med. 2022 11; 175(11):1582-1590.
-
Antidepressant medication use and prostate cancer recurrence in men with depressive disorders. Cancer Causes Control. 2022 Nov; 33(11):1363-1372.
-
MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets. Nat Commun. 2022 05 13; 13(1):2559.
-
Design of digital walking programs that engage prostate cancer survivors: Needs and preferences from focus groups. AMIA Annu Symp Proc. 2021; 2021:1069-1078.
-
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. Nat Genet. 2021 01; 53(1):65-75.
-
A Large-Scale Association Study Detects Novel Rare Variants, Risk Genes, Functional Elements, and Polygenic Architecture of Prostate Cancer Susceptibility. Cancer Res. 2021 04 01; 81(7):1695-1703.
-
Multicenter Comparison of 17-Gene Genomic Prostate Score as a Predictor of Outcomes in African American and Caucasian American Men with Clinically Localized Prostate Cancer. J Urol. 2021 Apr; 205(4):1047-1054.